Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Schatz

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Atherosclerosis. Supplements|January 30, 2013
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulationsU Schatz, B Arneth, G Siegert, et al.
Microvascular Research|March 31, 2009
Protein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cellsK Staiger, U Schatz, H Staiger, et al.
Atherosclerosis. Supplements|May 5, 2015
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltoseU Schatz, B M W Illigens, T Siepmann, et al.
Atherosclerosis. Supplements|November 4, 2017
Lipoprotein apheresis influences monocyte subpopulationsS Jellinghaus, C Reich, U Schatz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 9, 2023
High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in GermanyU Makhmudova, U Schatz, N Perakakis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Atherosclerosis. Supplements|January 30, 2013
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulationsU Schatz, B Arneth, G Siegert, et al.
Microvascular Research|March 31, 2009
Protein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cellsK Staiger, U Schatz, H Staiger, et al.
Atherosclerosis. Supplements|May 5, 2015
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltoseU Schatz, B M W Illigens, T Siepmann, et al.
Atherosclerosis. Supplements|November 4, 2017
Lipoprotein apheresis influences monocyte subpopulationsS Jellinghaus, C Reich, U Schatz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 9, 2023
High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in GermanyU Makhmudova, U Schatz, N Perakakis, et al.
Pageof 2